Roche Cuts Feasibility Process by 36%

An industry pioneer and veteran biotech, Roche, like other complex pharmaceutical organizations, struggled with complexity and consistency when it came to its approach to clinical trial feasibility, which led to some challenges for both site stakeholders and internal study teams.

Read how this organization was able to standardize its feasibility process.